SURVANTA
SURVANTA
Approved
DIN Number
02016109
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02016109
AIG Number0124200001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R07AA02 NATURAL PHOSPHOLIPIDS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntratracheal
AHFS Classification48:36.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BERACTANTActive
Strength: 25 MG / ML
Monograph: BERACTANT